Skip to main content

Articles

Leukemia, Oncology

Investigational Oral Form of Azacitidine Improves Survival Maintenance Therapy in Patients with Acute Myeloid Leukemia

Wayne Kuznar

Leukemia, Oncology

First-Line Acalabrutinib-Based Triplet Therapy Leads to Undetectable Minimal Residual Disease in CLL

Wayne Kuznar

Leukemia, Oncology

Zanubrutinib, Next-Generation BTK, Leads to Impressive Responses in Patients with CLL or SLL

Phoebe Starr

Apamistamab-Based Lymphodepleting Regimen Before CAR T-Cell Therapy May Prevent Cytokine Release Syndrome

Wayne Kuznar

FDA Approvals, Prostate Cancer

Xtandi Now Approved for Metastatic Castration-Sensitive Prostate Cancer

Keytruda Indicated for BCG-Unresponsive High-Risk, Non–Muscle Invasive Bladder Cancer

Ayvakit First Targeted Therapy Approved for Gastrointestinal Stromal Tumors with PDGFRA Mutation

Breast Cancer, FDA Approvals, Oncology

Enhertu, a Dual-Targeted Therapy, Approved for Metastatic HER2-Positive Breast Cancer

Padcev, a Novel Targeted Therapy, FDA Approved for Advanced or Metastatic Urothelial Cancer

Tazverik First FDA-Approved Drug for Advanced Epithelioid Sarcoma Ineligible for Resection

Page 39 of 244
Results 381 - 390 of 2440